Trial intelligence / Profile preview

Effectiveness of dydrogesterone and progesterone in prevention of preterm birth in women with a short cervix

IRCT20221107056426N1Phase 3Completed

Sponsor
Golestan University of Medical Sciences
Start
Nov 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of dydrogesterone and progesterone in Preterm labor (PTL) (2 arms), sponsored by Golestan University of Medical Sciences. Started Nov 2022; status: completed.

02

Drugs

dydrogesteroneprogesterone
03

Conditions

Preterm labor (PTL)

Beyond the preview

Go deeper on IRCT20221107056426N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20221107056426N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call